Pharmaceutical - Anti-virals, Pharmaceutical

Filter

Current filters:

Anti-viralsPharmaceutical

Popular Filters

1 to 25 of 323 results

More EMA/CHMP recommendations

23-01-2015

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval…

Anti-viralsAntibiotics and Infectious diseasesCubistDutrebisEuropeIkervisMerck & CoOphthalmicsPharmaceuticalSanten PharmaceuticalsSivextro

Merck & Co drops marketing of hepatitis C drug Victrelis in USA

Merck & Co drops marketing of hepatitis C drug Victrelis in USA

22-01-2015

In an open letter to pharmacy professions, US pharma giant Merck & Co has advised that it is voluntarily…

Anti-viralsMarkets & MarketingMerck & CoPharmaceuticalUSAVictrelis

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

19-01-2015

US health care giant Johnson & Johnson’s Europe-based subsidiary has formed consortia with several…

Anti-viralsEuropeJanssenPharmaceuticalResearchVaccines

EC approves AbbVie’s Viekirax + Exviera for hepatitis C

EC approves AbbVie’s Viekirax + Exviera for hepatitis C

16-01-2015

The European Commission has granted marketing authorizations for US drugmaker AbbVie’s all-oral, short-course,…

AbbVieAnti-viralsEuropeExvieraPharmaceuticalRegulationViekirax

EFPIA and Innovative Medicines Initiative announce new projects to fight Ebola

EFPIA and Innovative Medicines Initiative announce new projects to fight Ebola

16-01-2015

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Innovative Medicines…

Anti-viralsEuropeEuropean Federation of Pharmaceutical Industries and AssociationsMedicinePharmaceutical

Court orders SIGA to pay $195,000 in case brought by PharmAthene for Tecovirimat

Court orders SIGA to pay $195,000 in case brought by PharmAthene for Tecovirimat

16-01-2015

The Delaware Court of Chancery has entered its Final Order and Judgment in the case brought by US pharma…

Anti-viralsLegalPharmaceuticalPharmAtheneSIGA TechnologiesTecovirimatUSA

Merck & Co updates on plans to accelerate new drug submissions and future growth

Merck & Co updates on plans to accelerate new drug submissions and future growth

13-01-2015

US pharma giant Merck & Co has reported on the ongoing execution of its multi-year, strategic initiative…

Anti-viralsgrazoprevir/elbasvirKeytrudaMerck & CoOncologyPharmaceuticalRegulationResearchUSA

US insurance firm Anthem chooses Gilead’s Harvoni as primary HCV drug

US insurance firm Anthem chooses Gilead’s Harvoni as primary HCV drug

12-01-2015

US biotech major Gilead Sciences has signed an agreement with US health insurance firm Anthem to provide…

Anti-viralsGileadHarvoniPharmaceuticalPricingUSA

AbbVie issues earnings-per-share guidance up 30% for 2015

AbbVie issues earnings-per-share guidance up 30% for 2015

12-01-2015

US drugmaker AbbVie has issued updated guidance about its expected earnings in 2015.

AbbVieAnti-viralsFinancialHumiraPharmaceuticalUSAViekira Pak

ViiV’s Triumeq offers added benefit for treatment-naive adults with HIV, says IQWiG

ViiV’s Triumeq offers added benefit for treatment-naive adults with HIV, says IQWiG

08-01-2015

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG), which had already assessed a…

Anti-viralsGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationTriumeqViiV Healthcare

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

06-01-2015

US pharma giant Pfizer has acquired a controlling interest in Redvax GmbH, a spin-off from Redbiotec,…

Anti-viralsMergers & AcquisitionsPfizerPharmaceuticalRedbiotechRedvaxVaccines

Roche receives Emergency Use Authorization from FDA for its LightMix Ebola Zaire rRT-PCR Test

Roche receives Emergency Use Authorization from FDA for its LightMix Ebola Zaire rRT-PCR Test

29-12-2014

Swiss drug major Roche has received Emergency Use Authorization for its LightMix Ebola Zaire rRT-PCR…

Anti-viralsPharmaceuticalRegulationRocheWest Africa

Express Scripts says AbbVie’s Viekira Pak to be exclusive option for genotype 1 hepatitis C

Express Scripts says AbbVie’s Viekira Pak to be exclusive option for genotype 1 hepatitis C

22-12-2014

Express Scripts today announced an update to its National Preferred Formulary that will significantly…

AbbVieAnti-viralsExpress ScriptsGilead SciencesHarvoniPharmaceuticalPricingSovaldiUSAViekira Pak

FDA approves fourth hepatitis C drug, AbbVie’s Viekira Pak

FDA approves fourth hepatitis C drug, AbbVie’s Viekira Pak

20-12-2014

The US Food and Drug Administration on Friday confirmed the much anticipated approval of US pharma company…

AbbVieAnti-viralsPharmaceuticalRegulationUSAViekira Pak

GSK shingles vaccine candidate meets Ph III primary endpoint

GSK shingles vaccine candidate meets Ph III primary endpoint

18-12-2014

UK pharma major GlaxoSmithKline today released pivotal Phase III study data to assess the efficacy of…

AgenusAnti-viralsGlaxoSmithKlineHZ/suPharmaceuticalResearchVaccines

China's Ebola vaccine enters clinical trials

China's Ebola vaccine enters clinical trials

18-12-2014

An Ebola vaccine developed by a military-tied research institute has been approved to enter the human…

Anti-viralsChinaPharmaceuticalResearchVaccines

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

13-12-2014

French pharma major Sanofi’s vaccines division, Sanofi Pasteur, has received approval from the US Food…

Anti-viralsFluzonePharmaceuticalRegulationSanofiSanofi PasteurUSAVaccines

Merck and NewLink Ebola vaccine trial suspended as patients report joint pain

Merck and NewLink Ebola vaccine trial suspended as patients report joint pain

12-12-2014

Pharma giant Merck & Co’s Phase I trial of Ebola Vaccine VSV-ZEBOV, developed in conjunction with NewLink,…

Anti-viralsMerck & CoNewLink GeneticsPharmaceuticalResearchSwitzerland

Big savings on HIV drugs via pooled procurement expected by Global Fund

Big savings on HIV drugs via pooled procurement expected by Global Fund

12-12-2014

The Global Fund to Fight AIDS, Tuberculosis and Malaria is putting into place a new agreement for purchasing…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalPricing

Effective malaria control dramatically reduces deaths, but challenges remain, report warns

Effective malaria control dramatically reduces deaths, but challenges remain, report warns

09-12-2014

Effective malaria control has dramatically reduced the number of people dying from the disease since…

Anti-viralsAntibiotics and Infectious diseasesPharmaceuticalResearchRest of the World

Russia may face a shortage of drugs against HIV

Russia may face a shortage of drugs against HIV

02-12-2014

Russia may face a shortage of drugs against HIV, due to disruptions of state auctions for the public…

Anti-viralsHealthPharmaceuticalProductionRussia

Merck Ebola vaccine is well-tolerated by volunteers in early trials

Merck Ebola vaccine is well-tolerated by volunteers in early trials

02-12-2014

The Ebola vaccine developed by pharma giant Merck & Co and NewLink has been well-tolerated by trial volunteers…

Anti-viralsMerck & CoNewLink GeneticsPharmaceuticalResearch

Two batches of Novartis' Fluad taken off market for investigation in Italy after 13 deaths

Two batches of Novartis' Fluad taken off market for investigation in Italy after 13 deaths

01-12-2014

The Italian Medicines Agency (AIFA) has suspended two batches of Swiss drug major Novartis’ Fluad seasonal…

Anti-viralsFluadItalian Medicines AgencyItalyNovartisPharmaceuticalRegulation

1 to 25 of 323 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top